Bronchopulmonary Dysplasia
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
Results of the meta-analysis revealed that four up-regulated miRNAs (miRNA-21, miRNA-34a, miRNA-431, and Let-7f) and one down-regulated miRNA (miRNA-335) were differentially expressed in BPD lung tissues compared with normal groups.
|
24301780 |
2013 |
Glioblastoma
|
0.020 |
Biomarker
|
disease |
BEFREE |
Addition of HuIFN-β and transient transfection with miR-431 to medulloblastoma and glioblastoma cells did not reduce viability, downregulated expression of SOCS6, and concomitantly activated the JAK1 and STAT2.
|
24584142 |
2014 |
Glioblastoma Multiforme
|
0.020 |
Biomarker
|
disease |
BEFREE |
Addition of HuIFN-β and transient transfection with miR-431 to medulloblastoma and glioblastoma cells did not reduce viability, downregulated expression of SOCS6, and concomitantly activated the JAK1 and STAT2.
|
24584142 |
2014 |
Medulloblastoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
Addition of HuIFN-β and transient transfection with miR-431 to medulloblastoma and glioblastoma cells did not reduce viability, downregulated expression of SOCS6, and concomitantly activated the JAK1 and STAT2.
|
24584142 |
2014 |
Neoplasms
|
0.010 |
AlteredExpression
|
group |
BEFREE |
We aimed to demonstrate an antineoplastic effect of HuIFN-β via miR-431 expression against medulloblastoma and glioblastoma, because HuIFN-β is frequently used in adjuvant therapy of these tumors.
|
24584142 |
2014 |
Childhood Medulloblastoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
Addition of HuIFN-β and transient transfection with miR-431 to medulloblastoma and glioblastoma cells did not reduce viability, downregulated expression of SOCS6, and concomitantly activated the JAK1 and STAT2.
|
24584142 |
2014 |
Adult Medulloblastoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
Addition of HuIFN-β and transient transfection with miR-431 to medulloblastoma and glioblastoma cells did not reduce viability, downregulated expression of SOCS6, and concomitantly activated the JAK1 and STAT2.
|
24584142 |
2014 |
Adult Glioblastoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
Addition of HuIFN-β and transient transfection with miR-431 to medulloblastoma and glioblastoma cells did not reduce viability, downregulated expression of SOCS6, and concomitantly activated the JAK1 and STAT2.
|
24584142 |
2014 |
Childhood Glioblastoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
Addition of HuIFN-β and transient transfection with miR-431 to medulloblastoma and glioblastoma cells did not reduce viability, downregulated expression of SOCS6, and concomitantly activated the JAK1 and STAT2.
|
24584142 |
2014 |
Tumor Cell Invasion
|
0.070 |
AlteredExpression
|
phenotype |
BEFREE |
MiR-431 down-expression was correlated with multiple malignant characteristics, including lymph node metastasis (r = -0.455, P < 0.001), clinical TNM stage (r = -0.223, P = 0.030), MTDH (r = -0.292, P = 0.006), vaso-invasion (r = -0.204, P = 0.047), MVD (r = -0.281, P = 0.006) and HCV (r = 0.215, P = 0.037).
|
25775917 |
2015 |
Secondary malignant neoplasm of lymph node
|
0.020 |
AlteredExpression
|
disease |
BEFREE |
MiR-431 down-expression was correlated with multiple malignant characteristics, including lymph node metastasis (r = -0.455, P < 0.001), clinical TNM stage (r = -0.223, P = 0.030), MTDH (r = -0.292, P = 0.006), vaso-invasion (r = -0.204, P = 0.047), MVD (r = -0.281, P = 0.006) and HCV (r = 0.215, P = 0.037).
|
25775917 |
2015 |
Carcinoid Tumor
|
0.010 |
AlteredExpression
|
phenotype |
BEFREE |
MiR-409-3p, miR-409-5p and miR-431-5p were also significantly downregulated in carcinoids metastatic to the lymph nodes.
|
25791280 |
2015 |
melanoma
|
0.020 |
Biomarker
|
disease |
BEFREE |
While 12 out of 15 selected miRNAs by FMIMS corroborate with those of biological investigations, three of them viz., "hsa-miR-519," "hsa-miR-431" and "hsa-miR-320c" are possible novel predictions for renal cancer, lung cancer and melanoma, respectively.
|
26264058 |
2016 |
Spinal Muscular Atrophy
|
0.010 |
Biomarker
|
disease |
BEFREE |
Together, our findings indicate that cell-type-specific dysregulation of miR-431 plays a role in the SMA motor neuron phenotype.
|
27005422 |
2016 |
Papillary thyroid carcinoma
|
0.310 |
Biomarker
|
disease |
CTD_human |
Down-regulation of 14q32-encoded miRNAs and tumor suppressor role for miR-654-3p in papillary thyroid cancer.
|
28030816 |
2017 |
Neoplasms, Experimental
|
0.300 |
Biomarker
|
phenotype |
CTD_human |
Down-regulation of 14q32-encoded miRNAs and tumor suppressor role for miR-654-3p in papillary thyroid cancer.
|
28030816 |
2017 |
Nonmedullary Thyroid Carcinoma
|
0.300 |
Biomarker
|
disease |
CTD_human |
Down-regulation of 14q32-encoded miRNAs and tumor suppressor role for miR-654-3p in papillary thyroid cancer.
|
28030816 |
2017 |
Familial Nonmedullary Thyroid Cancer
|
0.300 |
Biomarker
|
disease |
CTD_human |
Down-regulation of 14q32-encoded miRNAs and tumor suppressor role for miR-654-3p in papillary thyroid cancer.
|
28030816 |
2017 |
Malignant Neoplasms
|
0.010 |
Biomarker
|
group |
BEFREE |
Furthermore, hsa-miR-323b-3p may be related to DLBCL by participating in pathways in cancer. hsa-miR-431-5p may also play a role in DLBCL by regulating FYN.
|
29128636 |
2018 |
Diffuse Large B-Cell Lymphoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
Furthermore, hsa-miR-323b-3p may be related to DLBCL by participating in pathways in cancer. hsa-miR-431-5p may also play a role in DLBCL by regulating FYN.
|
29128636 |
2018 |
Primary malignant neoplasm
|
0.010 |
Biomarker
|
group |
BEFREE |
Furthermore, hsa-miR-323b-3p may be related to DLBCL by participating in pathways in cancer. hsa-miR-431-5p may also play a role in DLBCL by regulating FYN.
|
29128636 |
2018 |
Cerebral Infarction
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
Rho expression and cerebral infarction were visualized by immunohischemistry and TTC staining, respectively. qRT-PCR and western blotting were used to measure mRNA and protein expression of miR-431 and Rho/Rho-kinase signaling pathway-related genes.
|
29227541 |
2018 |
Alzheimer's Disease
|
0.010 |
Biomarker
|
disease |
BEFREE |
Our findings demonstrate that miR-431 protects synapses and neurites from Aβ-toxicity in an AD cell culture model and may be a promising therapeutic target.
|
29643768 |
2018 |
Liver carcinoma
|
0.030 |
Biomarker
|
disease |
BEFREE |
These results suggest hsa_circ_0005075 promotes HCC via miR-431 regulation.
|
29710484 |
2018 |
Liver carcinoma
|
0.030 |
GeneticVariation
|
disease |
BEFREE |
These data suggest that the rs112395617 polymorphism may contribute to HCC susceptibility, in full or at least partially through an effect on <i>JAK1</i> transcriptional activity by disrupting its binding with miR-431-5p.
|
29731916 |
2018 |